China Medical System Lim... (CHSYF)

PNK: CHSYF · Real-Time Price · USD

0.93

-0.00 (-0.08%)

At close: May 01, 2025, 8:00 PM

China Medical System Income Statement

Financials in CNY. Fiscal year is January - December.

Fiscal Year	Q2 2024	Q4 2023	Q2 2023	Q4 2022	Q2 2022	Q4 2021	Q2 2021	Q4 2020	Q2 2020	Q4 2019	Q2 2019	Q4 2018	Q2 2018	Q4 2017	Q2 2017	Q4 2016	Q2 2016
Period Ending	Jun 30, 2024	Dec 31, 2023	Jun 30, 2023	Dec 31, 2022	Jun 30, 2022	Dec 31, 2021	Jun 30, 2021	Dec 31, 2020	Jun 30, 2020	Dec 31, 2019	Jun 30, 2019	Dec 31, 2018	Jun 30, 2018	Dec 31, 2017	Jun 30, 2017	Dec 31, 2016	Jun 30, 2016
Revenue	3.61B	3.4B	4.61B	4.7B	4.45B	4.49B	3.84B	3.84B	3.11B	3.11B	2.96B	2.78B	2.66B	2.66B	2.69B	2.72B	2.18B
Cost of Revenue	914.57M	933.1M	1B	1.1B	1.01B	1.12B	969.24M	997.08M	814.67M	780.43M	746.88M	745.28M	771.29M	846.14M	1.02B	1.08B	907.58M
Gross Profit	2.7B	2.47B	3.61B	3.6B	3.44B	3.37B	2.87B	2.84B	2.29B	2.33B	2.22B	2.03B	1.88B	1.82B	1.66B	1.64B	1.27B
Operating Income	828.96M	840.3M	1.87B	1.73B	1.82B	1.52B	1.63B	1.42B	1.34B	1.13B	1.22B	951M	1.05B	907.13M	967.05M	808.64M	707.79M
Interest Income	n/a	87.18M	43.67M	22.8M	39.39M	42.3M	22.97M	58.02M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Pretax Income	1.14B	591.18M	2.28B	1.71B	2.06B	1.64B	1.82B	1.35B	1.47B	1.19B	1.3B	961.24M	1.05B	951.59M	856.85M	802M	698.45M
Net Income	910.43M	479.88M	1.92B	1.46B	1.8B	1.39B	1.63B	1.25B	1.28B	790.82M	1.17B	892.34M	957.54M	869.85M	804.95M	722.14M	653.79M
Selling & General & Admin	1.76B	1.51B	1.66B	1.8B	1.56B	1.78B	1.2B	1.38B	924.56M	1.17B	977.87M	1.08B	833.7M	909.2M	694.92M	833.75M	561.73M
Research & Development	105.58M	119.39M	75.74M	69.88M	55.55M	77.91M	36.85M	36.16M	30.35M	29.62M	15.44M	n/a	n/a	n/a	n/a	n/a	n/a
Other Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Expenses	1.87B	1.63B	1.37B	1.92B	1.41B	1.77B	1.08B	1.54B	810.66M	1.14B	907.38M	1.07B	796.27M	830.21M	775.07M	835.2M	553.75M
Interest Expense	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	15.34M	2.71M	11.54M	n/a	n/a	n/a	n/a	n/a	n/a
Selling & Marketing Expenses	700.23M	1.17B	1.34B	1.44B	1.28B	1.5B	1.04B	1.23B	825.57M	1.06B	881.38M	937.43M	735.17M	784.48M	597.67M	713.58M	460.18M
Cost & Expenses	2.78B	2.56B	2.37B	3.02B	2.43B	2.89B	2.05B	2.54B	1.63B	1.92B	1.65B	1.81B	1.57B	1.68B	1.8B	1.92B	1.46B
Income Tax Expense	232.93M	122.7M	366.64M	227.26M	259.39M	246.7M	184.62M	93.5M	166.88M	400.97M	131.03M	71.79M	89.99M	85.73M	52.77M	78.29M	44.24M
Shares Outstanding (Basic)	2.44B	2.45B	2.45B	2.45B	2.46B	2.46B	2.47B	2.47B	2.47B	2.48B	2.48B	2.49B	2.49B	2.49B	2.49B	2.49B	2.49B
Shares Outstanding (Diluted)	2.44B	2.45B	2.45B	2.45B	2.46B	2.46B	2.47B	2.47B	2.47B	2.48B	2.48B	2.49B	2.49B	2.49B	2.49B	2.49B	2.49B
EPS (Basic)	0.37	0.20	0.78	0.60	0.74	0.56	0.66	0.50	0.52	0.32	0.48	0.36	0.38	0.34	0.32	0.30	0.26
EPS (Diluted)	0.37	0.20	0.78	0.60	0.74	0.56	0.66	0.50	0.52	0.32	0.48	0.36	0.38	0.34	0.32	0.30	0.26
EBITDA	943.02M	946.06M	1.98B	1.83B	1.93B	1.62B	1.74B	1.52B	1.44B	1.23B	1.32B	1.05B	1.15B	1.01B	1.06B	907.3M	784.99M
EBIT	828.96M	840.3M	1.87B	1.73B	1.82B	1.52B	1.63B	1.42B	1.34B	1.13B	1.22B	951M	1.05B	907.13M	967.05M	808.64M	707.79M
Depreciation & Amortization	114.06M	105.76M	103.55M	104.59M	104.49M	101.62M	104.43M	97.28M	99.78M	96.03M	98.47M	100.31M	98.69M	99.3M	97.12M	98.66M	77.2M